High Prevalence of Hypertension and Diabetes to Promote demand for Pelvic Floor Electric Stimulator Market

Published: Oct 2021

The global pelvic floor electric stimulator market is anticipated to grow at a considerable CAGR of 12.3% during the forecast period (2021-2027). The high prevalence of hypertension and diabetes is the major factor causing urinary incontinence which will drive the pelvic floor stimulator market during the forecast period. According to the WHO, around 1.13 billion people across the globe have hypertension and 422 million people have diabetes. Both diabetes and hypertension are also responsible for renal failure. 

Browse the full report description of "Global Pelvic Floor Electric Stimulator Market Size, Share & Trends Analysis Report by Product Type (Mobile, Fixed, and Wearable), by Device Type (Non-Implantable Electrical Stimulator Device and Implantable Electrical Stimulator Device), by Treatment (Pelvic Floor Muscle Training (PFMT), Intravaginal Neuromuscular Electrical Stimulation (NMES), and Transcutaneous Tibial Nerve Stimulation (TTNS)), and by Application (Urinary Incontinence, Sexual Dysfunction, and Neurodegenerative Diseases) Forecast Period (2021-2027)" at https://www.omrglobal.com/industry-reports/pelvic-floor-electric-stimulator-market

The National Centre for Biotechnology Information had estimated that globally around 5.0-7.0% of people suffer from end-stage renal diseases. The rising prevalence of these diseases is expected to drive the market of pelvic floor stimulators during the forecast period. Moreover, rising inclination of key medical device manufacturers to make advancement in their product offering to make them comfortable to use is driving the growth of the pelvic floor electric stimulator market across the globe. For instance, V2U Healthcare had exhibited its products in the medical fair organized in Thailand in September 2019. This has enabled the company to increase market awareness of its products.

Market Coverage

    • The market number available for – 2020-2027

    • Base year- 2020

    • Forecast period- 2021-2027

    • Segment Covered- 

o By Product Type

o By Device Type

o By Treatment

o By Application

    • Regions Covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

    • Competitive Landscape- Atlantic Therapeutics, ActivLife Technologies, Everyday Medical Instruments Co., Ltd., InControl Medical, Laborie, Inc., Renovia Inc., Zynex Inc., Verity Medical Ltd., V2U Healthcare, and others.

Key questions addressed by the report

    • What is the market growth rate?

    • Which segment and region dominate the market in the base year?

    • Which segment and region will project the fastest growth in the market?

    • How COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

    • Who is the leader in the market?

    • How players are addressing challenges to sustain growth?

    • Where is the investment opportunity?

Global Pelvic Floor Electric Stimulator Market Report Segment

By Product Type

    • Mobile

    • Fixed

    • Wearable

By Device Type

  • Non-Implantable Electrical Stimulator Device
  • Implantable Electrical Stimulator Device

By Treatment

    • Pelvic Floor Muscle Training (PFMT)

    • Intravaginal Neuromuscular Electrical Stimulation (NMES)

    • Transcutaneous Tibial Nerve Stimulation (TTNS)

By Application

    • Urinary Incontinence

    • Sexual Dysfunction

    • Neurodegenerative Diseases

Global Pelvic Floor Electric Stimulator Market Report Segment by Region

North America

    • United States

    • Canada

Europe

    • UK

    • Germany

    • Italy

    • Spain

    • France

    • Rest of Europe 

Asia-Pacific

    • China

    • India

    • Japan

    • South Korea

    • Rest of Asia-Pacific 

Rest of the World

    • Latin America 

    • Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/pelvic-floor-electric-stimulator-market